| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $81.3M | +1.7% | -16.4% |
| Cost of Revenue | $10.6M | -3.2% | -17.8% |
| R&D Expense | $2.1M | +0.0% | -18.1% |
| SG&A Expense | $18.8M | -4.9% | -16.5% |
| Operating Income | $17.8M | +20.3% | -18.6% |
| Pre-tax Income | $19.0M | +19.2% | -20.0% |
| Income Tax | $1.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.5M | -26.9% | -46.3% |
| Accounts Receivable | $4.1M | +1.9% | +86.5% |
| Current Assets | $117.0M | -10.0% | -32.2% |
| Total Assets | $201.7M | -4.8% | -27.6% |
| Current Liabilities | $229.2M | -4.3% | -19.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $21.7M | — | — |
| Capital Expenditures | $178K | — | — |
| Investing Cash Flow | -$1.0M | — | — |
| Financing Cash Flow | -$68.0M | — | — |
| Free Cash Flow | $21.6M | — | — |
| +74.2% |
| +9.8% |
| Net Income | $1.5M | +16.0% | -12.5% |
| EPS (Basic) | $0.60 | +9.1% | +1400.0% |
| EPS (Diluted) | $0.58 | +9.4% | +1350.0% |
| $427.6M |
| -2.5% |
| -18.6% |
| Stockholders' Equity | -$14.5M | +7.9% | +25.5% |